Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of the Reticuloendothelial Society|May 1, 1983
Effects of particulate beta-1,3 glucan on human, rat, and guinea pig complement activityM M Glovsky, L Cortes-Haendchen, L Ghekiere, et al.
Infection and Immunity|June 1, 1980
Adjuvant activity of a novel metabolizable lipid emulsion with inactivated viral vaccinesJ A Reynolds, D G Harrington, C L Crabbs, et al.
Hepatology (Baltimore, Md.)|March 1, 1985
Therapeutic efficacy of glucan in a murine model of hepatic metastatic diseaseD L Williams, E R Sherwood, R B McNamee, et al.
Journal of the National Cancer Institute|March 1, 1975
Macrophage-mediated destruction of human malignant cells in vivoP W Mansell, H Ichinose, R J Reed, et al.
International Journal of Immunopharmacology|January 1, 1987
Enhancement of interleukin-1 and interleukin-2 production by soluble glucanE R Sherwood, D L Williams, R B McNamee, et al.
Journal of Leukocyte Biology|July 1, 1987
In vitro tumoricidal activity of resting and glucan-activated Kupffer cellsE R Sherwood, D L Williams, R B McNamee, et al.
Journal of Biological Response Modifiers|April 1, 1988
Soluble glucan and lymphokine-activated killer (LAK) cells in the therapy of experimental hepatic metastasesE R Sherwood, D L Williams, R B McNamee, et al.
Hepatology (Baltimore, Md.)|November 1, 1987
Chemoimmunotherapy of experimental hepatic metastasesD L Williams, E R Sherwood, R B McNamee, et al.
Circulatory Shock|May 1, 1988
The role of complement in glucan-induced protection against septic shockD L Williams, E R Sherwood, I W Browder, et al.
Pageof 4